Identifying a Glycoprotein Linked to Normal and Cancerous Breast Cells
Author Information
Author(s): S.A. Imam, M.R. Stampfer, A. Yilmaz, C.R. Taylor
Primary Institution: University of Southern California School of Medicine
Hypothesis
Inactivation of tumor-suppressor genes plays an important role in the development of human malignancies.
Conclusion
The study found that the glycoprotein LEA.92 is present in normal mammary epithelial cells but absent in malignant cells, suggesting its potential role as a tumor marker.
Supporting Evidence
- LEA.92 was detected on normal mammary epithelial cells but not on malignant cells.
- The expression of LEA.92 correlated with non-tumorigenic cell lines.
- LEA.92 was also found in normal epithelial cells from other organs.
Takeaway
The researchers discovered a protein that is found on healthy breast cells but not on cancerous ones, which might help in understanding breast cancer.
Methodology
Monoclonal antibodies were generated using an immune tolerisation-immunisation procedure to identify the glycoprotein LEA.92.
Limitations
The precise genes involved in the loss of LEA.92 expression in malignant cells have not been determined.
Participant Demographics
Normal breast tissues were obtained from two young women undergoing reduction mammoplasty.
Want to read the original?
Access the complete publication on the publisher's website